nygazet.com logo
Pharma lobbyists focus on a surprising new target: the FDA
business

Pharma lobbyists focus on a surprising new target: the FDA

1 min read

FDA insists decisions are based on science, but lobbyists said they believe the odds of approval go up if a decision can be spun as a win for Trump.

WASHINGTON — Health secretary Robert F. Kennedy Jr. has repeatedly promised to root out industry influence from the Food and Drug Administration. But the Trump administration’s injection of political priorities into the agency, which has long been sh... [620 chars]

Read Original Article

Source: statnews.com

Visit Source

Share this article